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Abstract 4 
 5 
Background  6 
Enterococcal periprosthetic joint infections (PJIs) are rare after joint arthroplasty. These cases 7 
are usually reported in series of PJIs caused by other pathogens.  Because few studies have 8 
focused only on enterococcal PJIs, management and control of infection of these cases have not 9 
yet been well defined.   10 
Questions/Purposes  11 
We asked (1) what is the proportion of enterococcal PJI in our institutes; and (2) what is the rate 12 
of infection control in these cases? 13 
Methods  14 
We respectively identified 22 and 14 joints with monomicrobial and polymicrobial PJI, 15 
respectively, caused by enterococcus. The diagnosis of PJI was made based on the presence of 16 
sinus tract or two positive intraoperative cultures. PJI was also considered in the presence of one 17 
positive intraoperative culture and abnormal serology. We determined the proportion of 18 
enterococcal PJI and management and control of infection in these cases. Minimum follow-up 19 
was 1.5 years (mean, 3.2 years). 20 
Results  21 
The proportion of monomicrobial enterococcal PJI was 2.3% (22 of 955 cases of PJI). Mean 22 
number of surgeries was two (range, 1–4). Initial irrigation and de´bridement was performed in 23 
10 joints and eight patients needed reoperation. Seven of the 16 joints were initially managed 24 
using two-stage exchange arthroplasty and did not need further operation. Six patients had a 25 
definitive resection arthroplasty. Salvage surgeries (fusion and above-knee amputation) were 26 
performed in three cases (8%). The infection was ultimately controlled in 32 of the 36 patients. 27 
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Conclusions  28 
Management of enterococcal PJI is challenging and multiple operations may need to be 29 
performed to control the infection. 30 
Level of Evidence  31 
Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of 32 
evidence. 33 
 34 
Introduction 35 
 Periprosthetic joint infection (PJI) is one of the most challenging complications of joint 36 
arthroplasty [17]. PJI with an incidence of 1% to 4% after primary TKA [2, 15, 16] and 1% to2% 37 
after primary THA[10, 11] is one of the main causes of failure after joint arthroplasty [1, 4].  38 
Given the increasing number of primary joint arthroplasties being performed annually, an 39 
increasing number of joint arthroplasties complicated by PJI has been reported [5, 7, 19]. 40 
 Although in patients with PJI the most frequently cultured microorganisms are coagulase-41 
negative Staphylococci and Staphylococcus aureus, which are seen in 30% to 43% and 12% to 42 
23% of cases, respectively [21], it is estimated that Enterococcus species are responsible for 43 
approximately 3% of all PJIs [3]. Enterococcus is a Gram-positive, facultativel y anaerobic 44 
organism, which used to classify as Group D Streptococcus. Enterococcus species cause various 45 
types of infections, mainly nosocomial infection, endocarditis, urinary tract infection as well as 46 
intraabdominal and pelvic infections [8]. Although it is not a common pathogen for orthopaedic 47 
infections, there is a growing number of reports showing an increase in frequency of orthopaedic 48 
infection caused by Enterococcus [14, 18]. Probably as a result of the low frequency of 49 
enterococcal PJIs, these cases are usually reported in series of PJIs caused by other pathogens 50 
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[3]. Two studies [3, 18] focused on the treatment of patients with enterococcal PJI.  The first 51 
study was performed by El Helou et al. [3] in which 50 episodes of enterococcal PJI were 52 
evaluated. They found no difference between outcome of patients with enterococcal PJIs 53 
receiving combination therapy and those receiving monotherapy [3]. They also estimated 54 
survival free of treatment failure for various surgical approaches in the studied patients at 2 and 5 55 
years [3]. In the second study, management and control of infection in two vancomycin-resistant 56 
enterococcal PJIs were reported [18]. Studied patients had a complex course; one needed joint 57 
fusion and the other underwent resection arthroplasty.  Despite these two studies, frequency, 58 
management, and control of infection in patients with enterococcal PJI have not yet been well 59 
known. 60 
 In the present study, we therefore asked (1) what is the proportion of enterococcal PJI in 61 
our institutions; and (2) what is the rate of infection control in these cases? 62 
 63 
Patients and Methods 64 
 65 
 We retrospectively reviewed the electronic infection databases of two institutes to 66 
identify patients with a diagnosis of enterococcal PJI. The study covered the time period from 67 
2000 to 2010. PJI diagnosis was considered based on the new definition of PJI provided by the 68 
Musculoskeletal Infection Society [13]. Briefly, a diagnosis of PJI was made based on presence 69 
of sinus tract or two positive intraoperative cultures. PJI was also considered in the presence of 70 
one positive intraoperative culture and abnormal serology including erythrocyte sedimentation 71 
rate and C-reactive protein. Usually three to five intraoperative samples are taken in patients with 72 
suspicious PJI undergoing surgery in our institutes. During the study period we identified 955 73 
joints with PJI. For this study we included patients who met the definition for PJI and had at least 74 
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one positive intraoperative culture for any species of Enterococcus isolated either from solid 75 
medium or broth. Patients with positive culture for methicillin-resistant S aureus (MRSA) were 76 
excluded. According to the definition, we identified 36 total joint arthroplasties (19 hips and 17 77 
knees) with a diagnosis of PJI from two institutions. Enterococcus had been isolated at least from 78 
one culture in all patients. In 22 of the 36 cases, Enterococcus was the only isolated 79 
microorganism.  Vancomycin-resistant Enterococcus (VRE) was found in 12 cases (33%) (Table 80 
1). 81 
 The cohort consisted of 22 females and mean age of the studied patients at the time of 82 
first revision surgery was 66.1 years (range, 34–85 years). The minimum followup was 1.5 years 83 
(mean, 3.2 years; range, 1.5–10.5 years).  No patients were lost to followup. No patients were 84 
recalled specifically for this study; all data were obtained from medical records. Institutional 85 
Review Boards of both institutes approved the protocol for this study. 86 
 Initial irrigation and de´bridement was performed in 11 joints, one-stage revision in six 87 
joints, and two-stage exchange arthroplasty in 16 joints. Two more joints were scheduled to 88 
undergo two-stage exchange arthroplasty; however, at the time of the study, the reimplantation 89 
stage was not performed. Definitive resection arthroplasty was performed in one patient as the 90 
initial treatment. 91 
 In all patients, appropriate intravenous antibiotics were administered based on sensitivity 92 
test results for 4 to 6 weeks. Ampicillin, gentamicin, and vancomycin were antibiotics prescribed 93 
for non-VRE PJIs. Linezolid and daptomycin were administered for management of cases with 94 
VRE. In some patients we did not have details on chronic antibiotic suppression therapy and 95 
local antibiotic administration (Table 2). 96 
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 Patients were followed at 4 to 6 weeks, 6 months, and 1 year. AP and lateral radiographs 97 
of the joint were routinely obtained at each followup session. Patients were followed up by 98 
serology and if necessary aspiration and bone scan performed. 99 
 100 
 101 
Results 102 
 Of 955 joints with PJI, 36 patients had at least one culture with isolated Enterococcus 103 
spp. In 22 patients, the PJI was monomicrobial. The overall proportion of monomicrobial 104 
enterococcal PJI in the studied cohort was 2.3% (22 patients of 955 joints with PJI in both 105 
institutions). 106 
 The mean number of operations for management of PJI without considering number of 107 
operations performed for management of wound problems was 1.6 (range, 1–4).  Irrigation and 108 
de´bridement was performed in 11 patients as the initial treatment; however, eight of these 11 109 
patients needed reoperation to control the infection. In the six patients in whom a one-stage 110 
revision was the initial treatment, the components were still in place at latest followup but one 111 
patient needed later irrigation and de´bridement. Seven of the 16 patients initially managed using 112 
two-stage exchange arthroplasty did not need further surgery to control the infection. Two more 113 
patients were scheduled for two-stage exchange arthroplasty in that the second stage 114 
(reimplantation) was not performed during the study period. One of these patients needed spacer 115 
exchange. Definitive resection arthroplasty was performed as the initial management in one joint 116 
because the patient was not considered to be an appropriate candidate for twostage exchange. 117 
Five more patients ultimately needed definitive resection arthroplasty because the initial 118 
treatment failed to control the infection. Three patients had salvage surgery after failure of the 119 
initial treatment, including one fusion and two above-knee amputations (Table 2). Three patients 120 
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(8%) had died at the time of latest followup. Mean time from first revision to death was 4.4 years 121 
(range, 1.9–6.2 years). In one patient, Clostridium difficile colitis developed as a result of 122 
antibiotic therapy. One patient developed Stevens-Johnson syndrome resulting from chronic 123 
antibiotic suppression therapy. 124 
 125 
Discussion 126 
 127 
 PJI is one of the major causes of failure after joint arthroplasty [17]. Although S aureus 128 
and  oagulasenegative Staphylococci are traditionally the main pathogens for PJI, there are other 129 
microorganisms that can result in PJI. Enterococcus species are among the infrequent pathogens 130 
that are known to result in orthopaedic infections including PJI. Enterococcus is a Gram-positive, 131 
facultatively anaerobic organism, which used to be classified as Group D Streptococcus. 132 
Enterococcus causes various types of infections, mainly nosocomial infection, endocarditis, 133 
urinary tract infection as well as intraabdominal and pelvic infections [8]. As mentioned earlier, 134 
there are only two studies that merely focused on management and control of infection in 135 
patients with enterococcal PJI [3, 18] and frequency, management, and control of this type of PJI 136 
has not yet been well known in these patients. Our experience suggested that patients with 137 
enterococcal PJI were challenging to manage and the rate of infection control was lower in 138 
patients infected with nonenterococcal infections compared with other infections. This study 139 
aimed to determine the proportion of enterococcal PJI and to assess management and control of 140 
this type of PJI in two referral institutes. 141 
 Before discussing our results, it should be stated that this study has a few limitations. 142 
First, we encountered missing data on chronicity of PJIs (acute versus chronic), symptoms of 143 
patients at the time of first presentation, and antibiotic suppression therapy. Second, given the 144 
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complex course of these patients and lack of a universally accepted definition for success of 145 
surgical treatment of PJI, we did not perform survival analysis in our cohort. The majority of the 146 
patients in this study had multiple surgeries and depending on the definition, survival free of 147 
failure was low in our study and much lower than the cohort reported by El Helou et al. [3].  In 148 
the majority of patients in our cohort, PJI was ultimately controlled but at the expense of 149 
performing a considerable number of resection arthroplasties and salvage surgeries with or 150 
without chronic suppression antibiotic therapy that cannot be considered a favorable outcome. 151 
 The overall proportion of monomicrobial enterococcal PJIs in our cohort was in 152 
agreement with the reported incidence for enterococcal PJIs in the literature, which varies from 153 
2.5% to 3% [3]. To be able to compare the proportion of enterococcal PJI with a previous study 154 
[3], we considered only monomicrobial enterococcal PJIs to calculate the proportion of 155 
enterococcal PJI in our institutions.  However, we included polymicrobial PJIs in the final report 156 
on management and control of infection in these patients. We believe excluding patients with 157 
polymicrobial infections gives the opportunity for more accurate evaluation of enterococcal PJIs; 158 
it results in missing some polymicrobial PJIs in which Enterococcus is the major isolated 159 
pathogen. Moreover, it seems a considerable number of enterococcal PJIs are indeed 160 
polymicrobial PJIs [17]. 161 
 There are a number of treatment options available for patients with PJI in general that 162 
also apply to patients with enterococcal infections. These include a combination of medical 163 
(antibiotic therapy) and surgical treatments [12].  Regarding the antibiotic therapy, intravenous 164 
ampicillin, gentamicin, or vancomycin is sufficient for non-VRE species [8]. However, medical 165 
management of infected cases with VRE is more challenging and needs to be treated by either 166 
linezolid or daptomycin [20]. Irrigation and de´bridement, one-stage exchange arthroplasty, two-167 
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stage exchange arthroplasty, and salvage surgeries (fusion and amputation) are available surgical 168 
options for management of PJI. Among these options, two-stage exchange arthroplasty is the 169 
preferred method of treatment of patients with chronic PJI in North America [12]. The exact 170 
success rate of these interventions is not well known and varies widely depending on what is 171 
considered a success. One study from the Mayo Clinic evaluated the outcome of treatment for 50 172 
episodes of enterococcal PJI in 47 patients [3]. Among them, two-stage exchange arthroplasty 173 
was performed in 17 (34%) and irrigation and de´bridement with retention of prosthesis in five 174 
patients (10%). There was a relatively large cohort of patients (23 patients [46%]) who 175 
underwent resection arthroplasty without reimplantation.  One patient in that series required 176 
amputation. They estimated 2-year survival free of treatment failure as 94% for patients treated 177 
with two-stage exchange arthroplasty, 76% for patients treated with resection arthroplasty, and 178 
80% for patients treated with de´bridement and retention of the components. In another study, 179 
management and control of infection in two PJIs after TKA were reported [18]. The outcome in 180 
this small case series was poor because one patient needed resection arthroplasty and the other 181 
underwent fusion to control the infection. 182 
 There are a number of reasons that may explain the results of our study that is less 183 
optimal than a previous report by El Helou et al. [3]. We included patients with polymicrobial 184 
PJI, which may have confounded the outcome because some of these patients could have had 185 
sinus tract [6] and soft tissue defects, compromising outcome [21]. To minimize the effect of 186 
confounders, we excluded all patients in whom MRSA had been isolated at the same time 187 
because control of infection in patients with MRSA PJI is so challenging [9].  The other reason 188 
for higher failure is that fewer patients in our cohort underwent resection arthroplasty as the 189 
initial treatment. Nearly half of the patients in the Mayo Clinic series had resection arthroplasty 190 
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as their original operation [3]. The latter indicates those investigators had a higher threshold and 191 
were more selective in subjecting patients to two-stage exchange arthroplasty. Another 192 
explanation for our low rate of infection control may be the high percent of VRE-positive cases 193 
(33%) in our series because control of infection in these cases reportedly is so difficult [18]. 194 
Finally, the difference in the medical management between our institutions and the Mayo Clinic 195 
[3] may have also influenced the outcome. 196 
 Surprisingly, the six patients in our series who underwent one-stage exchange all had the 197 
prostheses in place at the last followup with infection well controlled. We assume that these 198 
patients had acute PJI with a short interval from development of PJI and performing the surgery, 199 
although we do not have accurate data in this regard to confirm our hypothesis. 200 
 Our data suggest that although enterococcal PJI is not frequent, management of these 201 
patients is challenging. These patients usually require multiple operations to control their 202 
infection and a considerable number of cases will ultimately undergo salvage surgery or 203 
resection arthroplasty. Performing more studies to determine the incidence of enterococcal PJI 204 
and to determine best management and control of infection in these patients is recommended. 205 
The current study highlights the shortcomings of the current treatment strategy and the desperate 206 
need for future developments. 207 
 208 
 209 
 210 
 211 
 212 
 213 
 214 
 215 
 216 
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